Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
EPS Over TimeExpanding
Percentile Rank79
3Y CAGR-48.3%
5Y CAGR-25.3%
Studio
Year-over-Year Change

Earnings per share

3Y CAGR
-48.3%/yr
Annual compound
5Y CAGR
-25.3%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM0.16+2736.4%
20240.01+100.1%
2023-6.45-670.8%
20221.13-65.3%
20213.26+386.6%
20200.67+782.3%
2019-0.10+94.7%
2018-1.85-134.2%
2017-0.79-41.1%
2016-0.56-